Literature DB >> 19019088

Evidence for a human leucocyte antigen-DM-induced structural change in human leucocyte antigen-DObeta.

Francis Deshaies1, Djibril A Diallo, Jean-Simon Fortin, Helen M O'Rourke, Abdul Mohammad Pezeshki, Angélique Bellemare-Pelletier, Nicola Raby, Nathalie Bédard, Alexandre Brunet, Lisa K Denzin, Jacques Thibodeau.   

Abstract

Human leucocyte antigen (HLA)-DO is a non-classical major histocompatibility complex class II molecule which modulates the function of HLA-DM and the loading of antigenic peptides on molecules such as HLA-DR. The bulk of HLA-DO associates with HLA-DM and this interaction is critical for HLA-DO egress from the endoplasmic reticulum. HLA-DM assists the early steps of HLA-DO maturation presumably through the stabilization of the interactions between the N-terminal regions of the alpha and beta chains. To evaluate a possible role for HLA-DM in influencing the conformation of HLA-DO, we made use of a monoclonal antibody, Mags.DO5, that was raised against HLA-DO/DM complexes. Using transfected cells expressing mismatched heterodimers between HLA-DR and -DO chains, we found that the epitope for Mags.DO5 is located on the DObeta chain and that Mags.DO5 reactivity was increased upon cotransfection with HLA-DM. Our results suggest that HLA-DM influences the folding of HLA-DO in the endoplasmic reticulum. A mutant HLA-DO showing reduced capacity for endoplasmic reticulum egress was better recognized by Mags.DO5 in the presence of HLA-DM. On the other hand, an HLA-DO mutant capable of endoplasmic reticulum egress on its own was efficiently recognized by Mags.DO5, irrespective of the presence of HLA-DM. Taken together, our results suggest that HLA-DM acts as a private chaperone, directly assisting the folding of HLA-DO to promote egress from the endoplasmic reticulum.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19019088      PMCID: PMC2712109          DOI: 10.1111/j.1365-2567.2008.02984.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  62 in total

Review 1.  Antigen processing: HLA-DO--a hitchhiking inhibitor of HLA-DM.

Authors:  P E Jensen
Journal:  Curr Biol       Date:  1998-02-12       Impact factor: 10.834

2.  HLA-DO is a negative modulator of HLA-DM-mediated MHC class II peptide loading.

Authors:  S M van Ham; E P Tjin; B F Lillemeier; U Grüneberg; K E van Meijgaarden; L Pastoors; D Verwoerd; A Tulp; B Canas; D Rahman; T H Ottenhoff; D J Pappin; J Trowsdale; J Neefjes
Journal:  Curr Biol       Date:  1997-12-01       Impact factor: 10.834

3.  A role for HLA-DO as a co-chaperone of HLA-DM in peptide loading of MHC class II molecules.

Authors:  H Kropshofer; A B Vogt; C Thery; E A Armandola; B C Li; G Moldenhauer; S Amigorena; G J Hämmerling
Journal:  EMBO J       Date:  1998-06-01       Impact factor: 11.598

4.  HLA-DM stabilizes empty HLA-DR molecules in a chaperone-like fashion.

Authors:  A B vogt; G Moldenhauer; G J Hämmerling; H Kropshofer
Journal:  Immunol Lett       Date:  1997-06-01       Impact factor: 3.685

5.  HLA-DO is an intracellular class II molecule with distinctive thymic expression.

Authors:  D C Douek; D M Altmann
Journal:  Int Immunol       Date:  1997-03       Impact factor: 4.823

6.  Negative regulation by HLA-DO of MHC class II-restricted antigen processing.

Authors:  L K Denzin; D B Sant'Angelo; C Hammond; M J Surman; P Cresswell
Journal:  Science       Date:  1997-10-03       Impact factor: 47.728

7.  Interaction between HLA-DM and HLA-DR involves regions that undergo conformational changes at lysosomal pH.

Authors:  H J Ullrich; K Döring; U Grüneberg; F Jähnig; J Trowsdale; S M van Ham
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-25       Impact factor: 11.205

8.  Altered antigen presentation in mice lacking H2-O.

Authors:  M Liljedahl; O Winqvist; C D Surh; P Wong; K Ngo; L Teyton; P A Peterson; A Brunmark; A Y Rudensky; W P Fung-Leung; L Karlsson
Journal:  Immunity       Date:  1998-02       Impact factor: 31.745

9.  Expression patterns of H2-O in mouse B cells and dendritic cells correlate with cell function.

Authors:  Jennifer L Fallas; Woelsung Yi; Nicole A Draghi; Helen M O'Rourke; Lisa K Denzin
Journal:  J Immunol       Date:  2007-02-01       Impact factor: 5.422

10.  HLA-DM interactions with intermediates in HLA-DR maturation and a role for HLA-DM in stabilizing empty HLA-DR molecules.

Authors:  L K Denzin; C Hammond; P Cresswell
Journal:  J Exp Med       Date:  1996-12-01       Impact factor: 14.307

View more
  4 in total

1.  Mapping the HLA-DO/HLA-DM complex by FRET and mutagenesis.

Authors:  Taejin Yoon; Henriette Macmillan; Sarah E Mortimer; Wei Jiang; Cornelia H Rinderknecht; Lawrence J Stern; Elizabeth D Mellins
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-25       Impact factor: 11.205

2.  HLA-DO as the optimizer of epitope selection for MHC class II antigen presentation.

Authors:  Yuri O Poluektov; Aeryon Kim; Isamu Z Hartman; Scheherazade Sadegh-Nasseri
Journal:  PLoS One       Date:  2013-08-08       Impact factor: 3.240

3.  HLA Immune Function Genes in Autism.

Authors:  Anthony R Torres; Jonna B Westover; Allen J Rosenspire
Journal:  Autism Res Treat       Date:  2012-02-15

4.  pH-susceptibility of HLA-DO tunes DO/DM ratios to regulate HLA-DM catalytic activity.

Authors:  Wei Jiang; Michael J Strohman; Sriram Somasundaram; Sashi Ayyangar; Tieying Hou; Nan Wang; Elizabeth D Mellins
Journal:  Sci Rep       Date:  2015-11-27       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.